Francesca Schiaretti
12Patents
3h-index
14Co-inventors
53Inventor score
Filing activity: Aug 2, 2011 → Feb 24, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9402825B2 | Dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic for administration by inhalation | Human Necessities | 6 | Active |
| US9808422B2 | Dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic for administration by inhalation | Human Necessities | 5 | Active |
| US9132121B2 | Dry powder formulation comprising a phosphodiesterase inhibitor | Human Necessities | 3 | Active |
| US10086004B2 | Process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic | Human Necessities | 1 | Active |
| US10350164B2 | Process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic | Human Necessities | 1 | Active |
| US10709666B2 | Carrier particles for dry powder formulations for inhalation | Human Necessities | 0 | Active |
| US11628175B2 | Process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic | Human Necessities | 0 | Active |
| US10772896B2 | Process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic | Human Necessities | 0 | Active |
| US10966991B2 | Process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic | Human Necessities | 0 | Active |
| US9308200B2 | Dry powder formulation comprising a phosphodiesterase inhibitor | Human Necessities | 0 | Active |
| US10583085B2 | Carrier particles for dry powder formulations for inhalation | Human Necessities | 0 | Active |
| US10786450B2 | Process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.